Ignite Creation Date:
2024-05-06 @ 1:41 AM
Last Modification Date:
2024-10-26 @ 11:08 AM
Study NCT ID:
NCT01873885
Status:
COMPLETED
Last Update Posted:
2014-04-10
First Post:
2013-06-06
Brief Title:
Phase 1 Randomized Double-Blind Placebo-Controlled Exploratory Study That Will Assess the Safety Tolerability Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera PB1046 in Adult Subjects With Stage 1 or 2 Essential Hypertension
Sponsor:
PhaseBio Pharmaceuticals Inc
Organization:
PhaseBio Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-06
First Submit QC Date:
June 6 2013
Study First Post Date:
2013-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-08
Last Update Post Date:
2014-04-10
Last Update Post Date Type:
ESTIMATED